ACTIVE

ESTEVE PHARMACEUTICALS

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result142,9 k €+254,2 %over 1 year

Revenue1,2 M €-9,8 %over 1 year

Equity834,4 k €+20,7 %over 1 year

Workforce0,0 ETP-100,0 %over 1 year

Identity

Source · BCE/KBO

ESTEVE PHARMACEUTICALS is a Private limited company incorporated in 2014. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Jette.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0543.727.164
Incorporation: 02/01/2014
Legal form: Private limited company
Registered office: Av. du Bourg. Etienne Demunter 5 box 10
1090 Jette · BruxellesSee on map
Contributed capital: 18 550,00 €
Latest accounts: 31/12/2024
Average workforce: 0,0 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 46150Agents involved in the sale of furniture, household goods, hardware and ironmongery 46150Agents involved in the sale of furniture, household goods, hardware and ironmongery

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityHealthy social debtsHigh revenue

Financials

Source · NBB, 11 filings

Trend over 11 financial years

	2024		2023		2022		2021		2020
Income statement
Revenue	1,2 M €	-9.8%	1,3 M €	-79.3%	6,4 M €	+26.4%	5,1 M €	-41.9%	8,7 M €
EBITDA	-63,4 k €	-143%	148,8 k €	-67.1%	451,6 k €	+326%	-199,9 k €	-145%	448,1 k €
Operating result	96,3 k €	+121%	43,5 k €	-89.0%	396,2 k €	+332%	91,7 k €	-45.3%	167,6 k €
Net result	142,9 k €	+254%	-92,7 k €	-134%	271,5 k €	+51840%	-524,7 €	-100%	111,7 k €
Balance sheet
Equity	834,4 k €	+20.7%	691,4 k €	-11.8%	784,2 k €	+53.0%	512,7 k €	-0.1%	513,2 k €
Total assets	1,4 M €	-64.2%	4 M €	+26.0%	3,2 M €	+8.3%	2,9 M €	-53.6%	6,3 M €
Cash	0 €	-100%	756,9 k €	-7.1%	814,5 k €	+90.3%	428 k €	+3.7%	412,6 k €
Debts	600,2 k €	-81.9%	3,3 M €	+38.3%	2,4 M €	-1.2%	2,4 M €	-58.3%	5,8 M €
Other
Workforce	0,0 ETP	-100%	0,3 ETP	-88.5%	2,6 ETP	-13.3%	3,0 ETP	+7.1%	2,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 18 ended

Active mandates

Ivan Hagay

Director · since 14 janvier 2025

Active

Jacob Tolstrup

Director · since 14 janvier 2025

Active

Ended mandates

Mira De Maeyer

Director · since 18 janvier 2023

Ended

Anja van Winsberghe

Chairman of the board of directors · since 18 novembre 2022

Ended

Christophe Van Damme

Director · since 18 novembre 2022 · until 18 janvier 2023

Ended

Sonia Alexis Hollies

Director · since 30 juin 2022

Ended

Other companies at this address

Av. du Bourg. Etienne Demunter 5 1090 Jette

Company	CBE no.
31.● Active	0540.821.421
ADW@WORK● Active	0471.485.920
AGATHA BELGIUM● Active	1038.495.361
Alpha Maintenance Belgium● Active	0767.410.649
ATHIX Bio● Active	0696.630.442
ATRIUM● Active	0475.331.969
AUGUSTINUS DAVID, BEDRIJFSREVISOR● Active	0793.811.376
AU PETIT CLIN D'OEIL● Active	0460.759.106
AUROBINDO● Active	0739.963.411
BAMEL● Active	0424.565.535
BINWEY● Active	0401.827.349
BLUECLIC PRODUCTIONS● Active	0870.031.701
BLUSUN● Active	0821.607.519
BUSWELL● Active	0465.988.790
CARROSSERIE KARREVELD● Active	0413.024.119
CK CONSTRUCT● Active	0895.913.378
COGELO BIS● Active	0896.856.753
COVERIA● Active	1039.647.483
Daring Hockey Dynamics● Active	0847.740.012
DRILLDOWN● Active	0452.163.124

Full financial information

Source · NBB

	2024	2023	2022	2021	2020	2019
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	01/07/2025	25/06/2024	05/06/2023	31/08/2022	03/08/2021	23/09/2020
General meeting	25/06/2025	29/05/2024	31/05/2023	31/08/2022	02/08/2021	31/08/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 11 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2024	25/06/2025	01/07/2025	Dutch	PDF
Full model	31/12/2023	29/05/2024	25/06/2024	French	PDF
Full model	31/12/2022	31/05/2023	05/06/2023	French	PDF
Full model	31/12/2021	31/08/2022	31/08/2022	French	PDF
Full model	31/12/2020	02/08/2021	03/08/2021	French	PDF
Full model	31/12/2019	31/08/2020	23/09/2020	French	PDF
Full model	31/12/2018	25/06/2019	02/08/2019	French	PDF
Full model	31/12/2017	29/06/2018	24/07/2018	French	PDF
Full model	31/12/2016	30/06/2017	14/07/2017	French	PDF
Full model	31/12/2015	30/06/2016	08/07/2016	French	PDF
Full model	31/12/2014	30/06/2015	23/07/2015	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 18 ended

Active mandates

Ivan Hagay

Director · since 14 janvier 2025

Active

Jacob Tolstrup

Director · since 14 janvier 2025

Active

Ended mandates

Mira De Maeyer

Director · since 18 janvier 2023

Ended

Anja van Winsberghe

Chairman of the board of directors · since 18 novembre 2022

Ended

Christophe Van Damme

Director · since 18 novembre 2022 · until 18 janvier 2023

Ended

Sonia Alexis Hollies

Director · since 30 juin 2022

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates20/11/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other04/03/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates04/02/2025
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares30/07/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - KAPITAAL - AANDELEN
PDF
Mandates26/07/2024
DEMISSIONS, NOMINATIONS
PDF
Capital / shares28/03/2024
CAPITAL, ACTIONS
PDF
Other24/11/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DIVERS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2024
Annual accounts 2024142,9 k €↑
2024
Name changeEsteve Pharmaceuticals
2023
Annual accounts 2023-92,7 k €↓
2022
Annual accounts 2022271,5 k €↑
2021
Annual accounts 2021-524,7 €↓
2020
Annual accounts 2020111,7 k €↓
2019
Annual accounts 2019132,4 k €↓
2018
Annual accounts 2018214,6 k €↑
2017
Annual accounts 201788 k €↑
2016
Annual accounts 201643,8 k €↑
2015
Annual accounts 2015-18,6 k €↓
2014
Annual accounts 2014-16,4 k €
2014
Name changeHRA Pharma Benelux
02/01/2014
IncorporationPrivate limited company

ESTEVE PHARMACEUTICALS

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline